Department of Medicine, Nazarbayev University School of Medicine, Kerei-Zhanibek Str. 5/1, 010000, Nur-Sultan, Kazakhstan.
RSE on REM Scientific-Production Center of Transfusion Medicine, Ministry of Health of the Republic of Kazakhstan, Nur-Sultan, Kazakhstan.
Intern Emerg Med. 2021 Mar;16(2):325-331. doi: 10.1007/s11739-020-02369-1. Epub 2020 May 30.
Behçet's disease (BD) is a systemic vasculitis whose prevalence varies according to the ethnicity. HLA-B51 is a well-known genetic factor predisposing to BD: populations with higher HLA-B51 allelic frequencies are also those with a greater disease prevalence, as occurs in the Silk Road countries. However, the BD prevalence is unknown in many countries, including Kazakhstan and, in general, Central Asia, despite the location on or near the Silk Road. Due to the lack of clinical studies from this area, we analyzed the bone marrow donors registry in Kazakhstan, in order to assess the HLA-B*51 allelic and carrier frequencies, which resulted to be 8.14 and 15.28%, respectively. Through a comparison with the same parameters in other countries (by performing a data search in the medical literature and in the Allele Frequency Net Database), we might speculate a BD prevalence in Kazakhstan of 10-15/100.000 at least. This result should prompt a greater clinical consideration of this disease in Central Asia, as well as the publication of clinical data from this geographic area.
贝赫切特病(BD)是一种系统性血管炎,其患病率因种族而异。HLA-B51 是已知的易患 BD 的遗传因素:具有更高 HLA-B51 等位基因频率的人群也具有更高的疾病患病率,就像丝绸之路国家一样。然而,包括哈萨克斯坦在内的许多国家都不知道 BD 的患病率,而且一般来说,中亚地区也是如此,尽管它们位于或靠近丝绸之路。由于该地区缺乏临床研究,我们分析了哈萨克斯坦的骨髓捐赠者登记处,以评估 HLA-B*51 等位基因和携带频率,结果分别为 8.14%和 15.28%。通过与其他国家的相同参数进行比较(在医学文献和 Allele Frequency Net 数据库中进行数据搜索),我们可以推测哈萨克斯坦的 BD 患病率至少为 10-15/100,000。这一结果应该促使中亚地区更加重视这种疾病,并公布该地理区域的临床数据。